2-54664588-G-A
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PP2BP4_ModerateBP6_ModerateBS1BS2
The NM_003128.3(SPTBN1):c.6556G>A(p.Ala2186Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTBN1 | NM_003128.3 | c.6556G>A | p.Ala2186Thr | missense_variant | 33/36 | ENST00000356805.9 | NP_003119.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTBN1 | ENST00000356805.9 | c.6556G>A | p.Ala2186Thr | missense_variant | 33/36 | 1 | NM_003128.3 | ENSP00000349259.4 | ||
SPTBN1 | ENST00000615901.4 | c.6562G>A | p.Ala2188Thr | missense_variant | 35/38 | 5 | ||||
SPTBN1 | ENST00000467371.1 | n.1688G>A | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
SPTBN1-AS2 | ENST00000626206.1 | n.466+10C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152046Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000175 AC: 44AN: 251444Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135898
GnomAD4 exome AF: 0.000247 AC: 361AN: 1461894Hom.: 0 Cov.: 30 AF XY: 0.000231 AC XY: 168AN XY: 727248
GnomAD4 genome AF: 0.000158 AC: 24AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74258
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at